• Register
  • Login
  • Home
  • Ahead of print
  • Current
  • Archives
  • Submissions
  • Supplements
  • About
    About the Journal Editorial Board Contact Privacy Statement
  • Login
  • Register
Journal of Gastrointestinal and Liver Diseases
Article References Download Details Statistics
  • PDF
  • Abstract viewed - 2973 times
  • PDF downloaded - 985 times

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Affiliations

Mar Riveiro-Barciela
Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid

Didac González-Sans
Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus and Universitat Autònoma de Barcelona, Barcelona, Spain

David Marmolejo
Oncology Department, Vall d’Hebron Institut of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

Maria-Teresa Salcedo
Pathology Department, Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

Eva Muñoz-Couselo
Oncology Department, Vall d’Hebron Institut of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

How to Cite

1.
Riveiro-Barciela M, González-Sans D, Marmolejo D, Salcedo M-T, Muñoz-Couselo E. Hepatic sinusoidal obstruction syndrome associated with nivolumab: an uncommon adverse event related to immune checkpoint inhibitors. JGLD [Internet]. 13Mar.2021 [cited 28Mar.2025];30(1):171-2. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/3207
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
Content Top

Hepatic sinusoidal obstruction syndrome associated with nivolumab: an uncommon adverse event related to immune checkpoint inhibitors

  1. Mar Riveiro-Barciela ,
  2. Didac González-Sans ,
  3. David Marmolejo ,
  4. Maria-Teresa Salcedo ,
  5. Eva Muñoz-Couselo

Vol 30 No 1: March 2021

Section: Letters

Pages: 171-172

DOI 10.15403/jgld-3207